| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1802430-56-3 | (6-Amino-3-chloro-2-fluorophenyl)boronic acid | C6H6BClFNO2 |
| 1802520-56-4 | ((E)-octadec-9-enyl)azanium iodide;Oleylammonium Iodide; (Z)-octadec-9-en-1-amine hydroiodide | C18H38IN |
| 1803084-79-8 | Repaglinide Impurity C;2-Desisopropyl-2-phenyl repaglinide | C30H34N2O4 |
| 1803583-30-3 | Ruxolitinib Diamine Impurity;4-{7H-pyrrolo(2,3-d)pyrimidin-4-yl}-1H-pyrazole hydrochloride | C9H8ClN5 |
| 1803604-98-9 | (3-Fluoroazetidin-3-yl)methanol hydrochloride | C4H9ClFNO |
| 1803606-63-4 | 3,3,3-Trifluoro-2,2-dimethylpropan-1-amine hydrochloride | C5H11ClF3N |
| 1803770-09-3 | 4-Fluoro-1,2-dihydro-2-oxo-3-pyridinecarboxylic acid | C6H4FNO3 |
| 1804177-30-7 | 5-Nitro-2-(1-oxopropyl)benzonitrile | C10H8N2O3 |
| 1804915-68-1 | Sodium ((2S,5R)-2-cyano-7-oxo-1,6-diazabicyclo(3.2.1)octan-6-yl) sulfate;WCK-4234 sodium | C7H8N3NaO5S |
| 1805112-73-5 | 2-Chloro-5-fluoro-3-methylbenzoic acid methyl ester | C9H8ClFO2 |
| 1805249-14-2 | 2-Bromo-4-fluoro-3-(trifluoromethyl)benzenamine | C7H4BrF4N |
| 1805269-43-5 | 2-Chloro-4-fluoropyridin-3-amine | C5H4ClFN2 |
| 1805421-04-8 | 2-Bromo-3-fluoro-5-methylbenzenamine | C7H7BrFN |
| 1805557-34-9 | 4-Bromo-6-nitro-3-pyridineacetic acid | C7H5BrN2O4 |
| 1805625-42-6 | 4-Amino-6-chloronicotinonitrile | C6H4ClN3 |
| 1805783-60-1 | (4''-Butyl-2'',3'',5'',6''-tetrafluoro-3-methoxy-2',4',6'-tris(1-methylethyl)(1,1':3',1''-terphenyl)-2-yl)bis(tricyclo(3.3.1.1(3,7))dec-1-yl)phosphine | C52H67F4OP |
| 1806321-10-7 | 3,5-Difluoro-4-methylbenzoic acid methyl ester | C9H8F2O2 |
| 1806469-15-7 | Pantoprazole Impurity 5;5-(Difluoromethoxy)-1,3-dihydro-2H-benzo(d)imidazol-2-one | C8H6F2N2O2 |
| 1807009-09-1 | 6-Bromo-2,3-dichlorobenzyl alcohol | C7H5BrCl2O |
| 1807056-85-4 | 1,2-Dibromo-4-fluoro-5-nitrobenzene | C6H2Br2FNO2 |
| 1807117-78-7 | 5-Bromo-3-fluoro-2-methylbenzonitrile | C8H5BrFN |
| 1807135-08-5 | 2-Bromo-1,5-difluoro-3-methylbenzene | C7H5BrF2 |
| 1807191-86-1 | 6-Bromo-3-fluoro-2-methylbenzoic acid methyl ester | C9H8BrFO2 |
| 1807197-86-9 | 2-Bromo-3,4-difluoropyridine | C5H2BrF2N |
| 1807221-07-3 | Ethyl 4-bromo-6-chloronicotinate | C8H7BrClNO2 |
| 1807224-98-1 | 1-Bromo-5-methoxy-4-methyl-2-nitrobenzene | C8H8BrNO3 |
| 1807232-33-2 | 2-Bromo-6-fluoro-4-methylbenzoic acid methyl ester | C9H8BrFO2 |
| 1807455-76-0 | 5-Chloro-N-(4-((5S)-5-((((5-chloro-2-thienyl)carbonyl)amino)methyl)-2-oxo-3-oxazolidinyl)phenyl)-N-(2-(2-(methylamino)-2-oxoethoxy)ethyl)-2-thiophenecarboxamide | C25H24Cl2N4O6S2 |
| 1807503-92-9 | 3-(2-(2-Bromoethoxy)ethoxy)propanoic acid | C7H13BrO4 |
| 1807529-70-9 | Cy5-Amine chloride hydrochloride;6-(6-((2E)-3,3-dimethyl-2-((2E,4E)-5-(1,3,3-trimethylindol-1-ium-2-yl)penta-2,4-dienylidene)indol-1-yl)hexanoylamino)hexylazanium;dichloride | C38H54Cl2N4O |
| 1807536-06-6 | 2-(4-Fluorophenyl)ethylamine Hydrobromide | C8H11BrFN |
| 1807607-93-7 | Bepotastine Isopropyl Ester;propan-2-yl 4-(4-((S)-(4-chlorophenyl)-pyridin-2-ylmethoxy)piperidin-1-yl)butanoate | C24H31ClN2O3 |
| 1807632-95-6 | Dapagliflozin Impurity 3;(2S,3R,4R,5S,6R)-2-(4-bromo-3-((4-ethoxyphenyl)methyl)phenyl)-6-(hydroxymethyl)oxane-3,4,5-triol | C21H25BrO6 |
| 1807758-81-1 | SIRT7 inhibitor 97491;3-N-(5-(4-chlorophenyl)-1,3-oxazol-2-yl)benzene-1,3-diamine | C15H12ClN3O |
| 1807861-48-8 | 2,4,6,7,8,9-Hexahydro-7-(phenylmethyl)-4-((4-(trifluoromethyl)phenyl)methyl)imidazo(1,2-a)pyrido(3,4-e)pyrimidin-5(1H)-one;ONC212;2,4,6,7,8,9-Hexahydro-7-(phenylmethyl)-4-((4-(trifluoromethyl)phenyl)methyl)imidazo(1,2-a)pyrido(3,4-e)pyrimidin-5(1H)-one | C24H23F3N4O |
| 1807920-97-3 | (2R)-2-amino-2-(3-(trifluoromethyl)bicyclo(1.1.1)pentan-1-yl)acetic acid hydrochloride | C8H11ClF3NO2 |
| 1807941-46-3 | 3-Methoxycyclobutanol | C5H10O2 |
| 1808248-05-6 | Linvencorvir;3-((8aS)-7-(((4S)-5-ethoxycarbonyl-4-(3-fluoro-2-methylphenyl)-2-(1,3-thiazol-2-yl)-1,4-dihydropyrimidin-6-yl)methyl)-3-oxo-5,6,8,8a-tetrahydro-1H-imidazo(1,5-a)pyrazin-2-yl)-2,2-dimethylpropanoic acid | C29H35FN6O5S |
| 1808997-73-0 | Tert-butyl 2-(cyanomethyl)piperazine-1-carboxylate | C11H19N3O2 |
| 1809010-50-1 | Berotralstat;2-(3-(aminomethyl)phenyl)-N-(5-((R)-(3-cyanophenyl)-(cyclopropylmethylamino)methyl)-2-fluorophenyl)-5-(trifluoromethyl)pyrazole-3-carboxamide | C30H26F4N6O |
| 1809249-37-3 | Remdesivir;GS 5734; 2-Ethylbutyl (2S)-2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)phenoxyphosphoryl)amino)propanoate; 2-Ethylbutyl N-((S)-(2-C-(4-aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-2,5-anhydro-D-altrononitril-6-O-yl)phenoxyphosphoryl)-L-alaninate | C27H35N6O8P |
| 1810004-87-5 | 3,6-Di-tert-butyl-9-mesityl-10-phenylacridinium Tetrafluoroborate | C36H40BF4N |
| 1810068-30-4 | 2'-(Bis(3,5-bis(trifluoromethyl)phenyl)phosphino)-3',6'-dimethoxy-N2,N2,N6,N6-tetramethyl-(1,1'-biphenyl)-2,6-diamine | C34H29F12N2O2P |
| 1810068-31-5 | Bis(3,5-bis(trifluoromethyl)phenyl)(3,6-dimethoxy-2',6'-bis(1-methylethoxy)(1,1'-biphenyl)-2-yl)phosphine | C36H31F12O4P |
| 1810068-32-6 | CPhos Pd G4;(2'-(Dicyclohexylphosphino-?P)-N2,N2,N6,N6-tetramethyl(1,1'-biphenyl)-2,6-diamine)(methanesulfonato-?O)(2'-(methylamino-?N)(1,1'-biphenyl)-2-yl-?C)palladium | C42H56N3O3PPdS |
| 1810069-89-6 | 7-Methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | C11H15N.HCl |
| 1812890-23-5 | 6,7-Dihydro-N-methyl-N-((3R,4R)-4-methyl-3-piperidinyl)-5H-pyrrolo(2,3-d)pyrimidin-4-amine | C13H21N5 |
| 1814936-54-3 | (SP-4-1)-(1,3-Bis(2,6-bis(1-propylbutyl)phenyl)-4,5-dichloro-1,3-dihydro-2H-imidazol-2-ylidene)dichloro(3-chloropyridine-κN)-Palladium;3-chloropyridine;4,5-dichloro-1,3-bis(2,6-di(heptan-4-yl)phenyl)-2H-imidazole dichloropalladium | C48H72Cl5N3Pd |
| 1815608-51-5 | Para-Vortioxetine Impurity;1-{4-((2,4-Dimethylphenyl)sulfanyl)phenyl}piperazine | C18H22N2S |
| 1816254-91-7 | n-Butyldi(tert-butyl)phosphonium tetrafluoroborate;butyl(ditert-butyl)phosphanium;tetrafluoroborate | C12H28BF4P |